UAE Launches Next-Gen GPS-Less Navigation and Secure Flight Control to Strengthen Aviation Security
VentureOne and ADASI Partner to Integrate Advanced Autonomous Flight Technologies Powered by TII – Perceptra and Saluki Unveiled at IDEX 2025
As dual-use technologies increasingly drive economies of scale worldwide, ADASI, a leader in UAV system manufacturing, has announced their adoption of two advanced autonomous flight technologies by Abu Dhabi’s VentureOne: Perceptra, a new cutting-edge GPS-less navigation technology, and Saluki, a high-security flight control technology for autonomous systems.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250218620933/en/

UAE Launches Next-Gen GPS-Less Navigation and Secure Flight Control to Strengthen Aviation Security (Photo: AETOSWire)
These technologies, both developed by the Technology Innovation Institute, are designed to deliver secure, resilient operations in the most challenging environments. They have been optimized for UAV manufacturers, offering enhanced resilience, precision, and security for autonomous aerial operations. The agreement between VentureOne, ADASI, and TII was formalized at IDEX 2025, the Middle East’s largest defense exhibition, at which Saluki and Perceptra were unveiled.
Global Positioning System (GPS) technology has long been a fundamental pillar of navigation, supporting applications from everyday smartphone use to critical defense and military operations. However, this widespread reliance on GPS has exposed vulnerabilities that can be exploited through techniques like jamming and spoofing. Jamming occurs when signals on the same frequency overwhelm GPS receivers, preventing accurate location tracking, while spoofing involves transmitting counterfeit signals to deceive receivers into calculating incorrect positions or times. These vulnerabilities pose significant risks across sectors that depend on precise navigation, including autonomous drones, commercial aviation, and military aircraft.
In defense and security, compromised GPS signals can impact mission success and personnel safety, while in aviation, navigation errors may cause flight path deviations and operational disruptions – reports of which have the aviation industry and international regulators such as IATA and European regulator EASA seeking urgent solutions for GPS interference, according to one Reuters report in 2024.
For autonomous systems like drones and self-driving vehicles, the inability to maintain accurate positioning can create safety hazards, particularly in dynamic or high-risk environments, from aviation to defense. As the use of GPS-dependent systems continues to grow, the need for resilient, alternative navigation solutions has become increasingly critical. Perceptra and Saluki overcome many of today’s numerous challenges with advanced vision-based navigation, delivering reliable, resilient performance.
Dr. Najwa Aaraj, CEO of TII, said, “Perceptra, with its GPS-less capabilities, and Saluki, with its sophisticated Zero Trust architecture, represent a significant leap in autonomous navigation with the potential to transform multiple sectors. From supporting safe travel in commercial flights, search-and-rescue missions with precise navigation, to enabling efficient urban drone logistics for deliveries in densely populated cities, these technologies have broad real-world applications. Their adaptability also makes them invaluable in defense, ensuring secure and resilient operations in even the most challenging environments. This collaboration reflects our commitment to developing advanced, dual-use technologies that serve both civilian and defense needs while positioning the UAE as a leader in next-generation autonomous systems.”
Perceptra is a vision-based system that ensures reliable navigation without GPS, allowing aerial platforms to operate in GNSS-denied environments. It features visual relocking, low navigation errors, and easy integration across platforms for intelligence, surveillance, reconnaissance, and electronic warfare.
Saluki is a secure, high-performance flight controller and mission computer with Zero Trust architecture. With PX4 compatibility, Gen AI capabilities, and 300 TOPS compute power, it supports multi-vehicle management for mission-critical defense applications.
“At ADASI, we integrate only the most advanced, field-proven technologies to ensure our UAVs operate with unmatched precision, resilience, and security, even in the most contested environments,” said Juma Al Kaabi, the CEO of ADASI. “Perceptra and Saluki provide exactly what next-generation UAVs require: secure, GPS-independent navigation and AI-powered mission control.”
“VentureOne is dedicated to ensuring that cutting-edge research becomes reality to make a positive impact and transform industries,” said Reda Nidhakou, the Acting CEO of VentureOne. “Saluki and Perceptra are just two of many new innovations to come that will help ensure more resilient and safer drone operations in different sectors, starting with defense. We are working on a more comprehensive air autonomy and security portfolio that will play a central role in future drone operations.”
Last week, TII announced its collaboration with the General Civil Aviation Authority (GCAA) to support regulatory efforts by developing advanced methodologies for air corridor design. These methodologies aim to optimize flight routes and reduce the risk of aerial incidents in complex urban airspaces, ensuring safe and efficient navigation for both piloted and autonomous drone taxis. These efforts, alongside Perceptra and Saluki, reinforce Abu Dhabi’s vision to lead in next-generation navigation and AI-powered autonomy.
Both VentureOne and TII are part of the Advanced Technology Research Council (ATRC), which oversees Abu Dhabi’s research and development ecosystem to advance transformative technologies with global impact. ADASI is part of the EDGE Group, the advanced technology and defense conglomerate.
Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20250218620933/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Aspect Announces CEO Leadership Transition and New Independent Board7.1.2026 00:13:00 CET | Press release
Aspect, a leading provider of cloud-based workforce management solutions, has announced a leadership transition, including the appointment of Jeff Kupietzky as Interim Chief Executive Officer and the formation of a new independent Board of Directors, marking an important next chapter for the company. As part of this transition, Darryl Kelly will step down as Chief Executive Officer and transition into a Strategic Advisor role, effective January 1, 2026. Darryl led Aspect through a pivotal period of transformation, helping reposition the business, refine its vision, and reinvigorate its innovation and execution. The company and its stakeholders thank Darryl for his leadership and contributions during a period of meaningful change. With Darryl continuing as Strategic Advisor, the organization retains continuity for employees, customers, and stakeholders. “Aspect is starting a new season, building upon the strong foundation we’ve created together,” said Darryl Kelly. “This transition is a
Brenus Pharma Reports Favorable Tolerability and Clinical Signals in Early Preliminary Results of First-In-Human Study for STC-1010 in Unresectable Metastatic Stage Colorectal Cancer (MSS CRC) Patients6.1.2026 21:00:00 CET | Press release
Brenus Pharma, a clinical stage biotechnology company unlocking the immune system in vivo to fight solid tumors, announced the successful completion of the first dose levels in its ongoing first-in-human study. The multi-center, open-label trial (NCT06934538) is a phase Ia/Ib study designed to evaluate safety, tolerability and preliminary clinical activity of STC-10101 in a first line setting. It will include in vivo analysis of immune and tumor dynamics during dose escalation of treatment and cohort extension to patients with unresectable locally advanced (stage IIIC, T4b) or unresectable metastatic (stage IV) MSS2 colorectal cancer (CRC). Early findings indicate that the first dose levels have been successfully completed with good overall tolerance and no-dose-limiting toxicities observed to date. “We are pleased to report that the safety profile observed to date is good and consistent with our expectations with no DLT,” said Paul Bravetti, CEO of Brenus Pharma. “Moreover, preliminar
SPIE, the International Society for Optics and Photonics, Announces Its 2026 Fellows6.1.2026 20:35:00 CET | Press release
The Society is welcoming 40 new Fellow Members from across the globe SPIE, the international society for optics and photonics, welcomes 40 Members as new Fellows of the Society in the 2026 cohort. They join their Fellow Member colleagues in being honored for their excellent technical achievements, as well as for their substantial service to the optics and photonics community and to SPIE. Fellows are Members of the Society who have made significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and imaging. Since the Society's inception in 1955, more than 1,800 SPIE Members have become Fellows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106630672/en/ SPIE, the international society for optics and photonics, announces its 2026 Fellows This year’s inductees are high-profile leaders in academia, industry, and government, many of whom are particularly prominent in their support
Chemelex Adds Electric Heat Trace Group Ltd.’s SmartTrace Monitoring Platform to its Heat Tracing Portfolio6.1.2026 20:00:00 CET | Press release
Chemelex, a global leader in electric thermal and sensing solutions, today announced the successful completion of its acquisition of substantially all the assets and ongoing operations of Electric Heat Trace Group Ltd. (EHT Group), headquartered in Ontario, Canada. This strategic move marks an exciting start to the new year and reinforces Chemelex’s commitment to delivering smarter, data-driven solutions for industrial heat trace systems. EHT Group is a recognized innovator in heat trace management, offering advanced software, integrated controller solutions, wireless communication modules, and comprehensive field services. Its flagship platform, SmartTrace, is a robust solution available in both cloud-based and on-premises deployments that enables predictive maintenance, minimizes downtime, and provides secure remote monitoring—helping customers achieve greater reliability and operational efficiency. This endeavor will help Chemelex support greater operational efficiencies for our cus
ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEA6.1.2026 19:30:00 CET | Press release
Combination therapy showed compelling survival and disease control compared to current standard, regardless of PD-L1 statusHigh GEA burden in Asia, where BeOne holds ZIIHERA rights, signals potential broad patient impactResults to be presented as a Late-Breaking Abstract Oral Presentation at ASCO GI on January 8, 2026 BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced full results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), a HER2-targeted bispecific antibody, in combination with chemotherapy, with and without PD-1 inhibitor TEVIMBRA® (tislelizumab), as a first-line treatment for HER2-positive (HER2+) locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). These data, including the first interim overall survival (OS) analysis, will be presented as a Late-Breaking Abstract Oral Presentation (#LBA285) at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) on
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom